Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
血清淀粉样蛋白P组分抗体治疗心脏淀粉样变性患者的药效学评价和安全性评估：一项开放标签的II期研究和一项辅助免疫PET成像研究
期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-021-02407-6
Wechalekar, Ashutosh; Antoni, Gunnar; Al Azzam, Wasfi; Bergström, Mats; Biswas, Swethajit; Chen, Chao; Cheriyan, Joseph; Cleveland, Matthew; Cookson, Louise; Galette, Paul; Janiczek, Robert L; Kwong, Raymond Y; Lukas, Mary Ann; Millns, Helen; Richards, Duncan; Schneider, Ian; Solomon, Scott D; Sörensen, Jens; Storey, James; Thompson, Douglas; van Dongen, Guus; Vugts, Danielle J; Wall, Anders; Wikström, Gerhard; Falk, Rodney H
